Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Murine complement C4 is not required for experimental autoimmune encephalomyelitis.

Laura A Boos1, Alexander J Szalai, Scott R Barnum

  • 1Department of Microbiology, University of Alabama, Birmingham, Alabama 35294, USA.

Glia
|September 25, 2004
PubMed
Summary

The classical complement pathway does not significantly impact experimental autoimmune encephalomyelitis (EAE), a multiple sclerosis model. The alternative pathway, however, is crucial for complement

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Oncology Guided by Genomic Profiling in Breast Cancer: Real-World Data from a Molecular Tumor Board.

Cancers·2025
Same author

Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment.

JTO clinical and research reports·2024
Same author

Immortalized Human Conjunctival Epithelial Cells Produce Functional Complement C3 and C4 Proteins.

Cornea·2023
Same author

A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer.

Scientific reports·2023
Same author

Editorial: The impact of COVID-19 on immune system-related complications in surgical patients.

Frontiers in surgery·2023
Same author

Clustering Patients With Gout Based on Comorbidities and Biomarkers: A Cross-Sectional Study.

The Journal of rheumatology·2022

Area of Science:

  • Neuroimmunology
  • Complement System Biology

Background:

  • Myelin and myelin proteins activate complement pathways.
  • Mice lacking complement factor B show reduced experimental autoimmune encephalomyelitis (EAE).
  • The role of the classical complement pathway in EAE pathogenesis is unknown.

Purpose of the Study:

  • To investigate the contribution of the classical complement pathway to EAE pathogenesis.
  • To compare EAE severity in C4-deficient mice versus wild-type mice.

Main Methods:

  • Experimental autoimmune encephalomyelitis (EAE) induced in C4-deficient (C4-/-) mice and controls.
  • Assessment of disease onset, severity, and tempo.
  • Analysis of cellular infiltration (macrophages, T cells) and demyelination.
  • Quantification of pro-inflammatory cytokines using ribonuclease protection assays.

Related Experiment Videos

Main Results:

  • Classical pathway deficiency (C4-/-) did not alter EAE onset, severity, or tempo.
  • Cellular infiltration and demyelination levels were similar between C4-/- and control mice.
  • Pro-inflammatory cytokines (IL-1beta, IL-18, TNF-alpha, IP-10, RANTES) were elevated in C4-/- mice with EAE.

Conclusions:

  • The classical complement pathway plays a minimal role in the pathogenesis of myelin oligodendrocyte-induced EAE.
  • The alternative complement pathway is the primary driver of complement-mediated pathology in this EAE model.
  • These findings highlight the distinct roles of complement pathways in demyelinating diseases.